By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IBM will collaborate with researchers at the University of Melbourne in Australia to provide life sciences researchers in the area with access to high-performance computing, including IBM's Blue Gene, to conduct a range of human disease studies.

The collaboration will involve IBM's Research Computational Biology Center, the Victorian Life Sciences Computational Initiative (VLSCI), and as many as 10,000 other researchers spread around the Melbourne area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."